SAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced ...

Zimmer Biomet (ZBH) could be a strong choice for your investment portfolio, due to its high cash yield, solid fundamentals, and discounted valuation. Companies like this have the capacity to leverage ...

In the eyes of one medtech executive, the most impressive innovation in the field over the past couple of years “comes down to connection.” In the past, medical device companies operated in silos, ...

WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Zimmer Biomet (ZBH) stock ought to be on your radar. Here's why – it is presently trading within the support range ($83.17 – $91.93), levels from which it has rebounded significantly in the past. Over ...

WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...

Zimmer Biomet Holdings Inc. (NYSE:ZBH) ranks among the best medical device stocks to invest in. Zimmer Biomet Holdings Inc. (NYSE:ZBH) announced on October 7 that it successfully acquired Monogram ...

Orthopedic technology company Zimmer Biomet hoping that the recent acquisition of Monogram technology, an Artificial intelligence-based orthopedic robotics tech company, will make getting an ...

Zimmer Biomet has completed its $177 million acquisition of Monogram Technologies, an orthopedic robotics company. The acquisition expands Zimmer’s suite of orthopedic robotics by adding Monogram’s ...

The first punch has been thrown in what’s shaping up to be a brawl between two well-respected global companies, one of them headquartered in northeast Indiana. A $69 million contract between Zimmer ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99. The orthopedic implant maker reported ...